5 (162) In stock
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
Elixir
John Martin on LinkedIn: CRISPR 'barcodes' map mammalian development in exquisite detail
Home – Articles, Analysis, Opinion – The Conversation – page 502
New Technique Limits CRISPR-Cas9 Off-Target Mutations
Greg Findlay's Instagram, Twitter & Facebook on IDCrawl
New insights on CRISPR/Cas9-based therapy for breast Cancer, Genes and Environment
CRISPR in cancer biology and therapy
Ovarian cancer – News, Research and Analysis – The Conversation – page 1
Genome editing and cancer: How far has research moved forward on CRISPR/Cas9? - ScienceDirect
Overcoming Barriers of CRISPR Gene Editing in iPS Cells
Home – Articles, Analysis, Opinion – The Conversation – page 497